Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 Sep;85(5):772–779. doi: 10.1054/bjoc.2001.1976

Initiation of human colon cancer cell proliferation by trypsin acting at protease-activated receptor-2

D Darmoul 1, J-C Marie 1, H Devaud 1, V Gratio 1, M Laburthe 1
PMCID: PMC2364111  PMID: 11531266

Abstract

The protease-activated receptor-2 (PAR-2) is a G protein-coupled receptor that is cleaved and activated by trypsin. We investigated the expression of PAR-2 and the role of trypsin in cell proliferation in human colon cancer cell lines. A total of 10 cell lines were tested for expression of PAR-2 mRNA by Northern blot and RT-PCR. PAR-2 protein was detected by immunofluorescence. Trypsin and the peptide agonist SLIGKV (AP2) were tested for their ability to induce calcium mobilization and to promote cell proliferation on serum-deprived cells. PAR-2 mRNA was detected by Northern blot analysis in 6 out of 10 cell lines [HT-29, Cl.19A, Caco-2, SW480, HCT-8 and T84]. Other cell lines expressed low levels of transcripts, which were detected only by RT-PCR. Further results were obtained with HT-29 cells: (1) PAR-2 protein is expressed at the cell surface; (2) an increase in intracellular calcium concentration was observed upon trypsin (1–100 nM) or AP2 (10–100 μM) challenges; (3) cells grown in serum-deprived media supplemented with trypsin (0.1–1 nM) or AP2 (1–300 μM) exhibited important mitogenic responses (3-fold increase of cell number). Proliferative effects of trypsin or AP2 were also observed in other cell lines expressing PAR-2. These data show that subnanomolar concentrations of trypsin, acting at PAR-2, promoted the proliferation of human colon cancer cells. The results of this study indicate that trypsin could be considered as a growth factor and unravel a new mechanism whereby serine proteases control colon tumours. © 2001 Cancer Research Campaign http://www.bjcancer.com

Keywords: colon cancer, proliferation, protease-activated receptor-2, trypsin, serine protease

Full Text

The Full Text of this article is available as a PDF (133.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Augeron C., Laboisse C. L. Emergence of permanently differentiated cell clones in a human colonic cancer cell line in culture after treatment with sodium butyrate. Cancer Res. 1984 Sep;44(9):3961–3969. [PubMed] [Google Scholar]
  2. Belham C. M., Tate R. J., Scott P. H., Pemberton A. D., Miller H. R., Wadsworth R. M., Gould G. W., Plevin R. Trypsin stimulates proteinase-activated receptor-2-dependent and -independent activation of mitogen-activated protein kinases. Biochem J. 1996 Dec 15;320(Pt 3):939–946. doi: 10.1042/bj3200939. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bernard-Perrone F., Carrere J., Renaud W., Moriscot C., Thoreux K., Bernard P., Servin A., Balas D., Senegas-Balas F. Pancreatic trypsinogen I expression during cell growth and differentiation of two human colon carcinoma cells. Am J Physiol. 1998 Jun;274(6 Pt 1):G1077–G1086. doi: 10.1152/ajpgi.1998.274.6.G1077. [DOI] [PubMed] [Google Scholar]
  4. Blackhart B. D., Emilsson K., Nguyen D., Teng W., Martelli A. J., Nystedt S., Sundelin J., Scarborough R. M. Ligand cross-reactivity within the protease-activated receptor family. J Biol Chem. 1996 Jul 12;271(28):16466–16471. doi: 10.1074/jbc.271.28.16466. [DOI] [PubMed] [Google Scholar]
  5. Blasi F., Stoppelli M. P. Proteases and cancer invasion: from belief to certainty. AACR meeting on proteases and protease inhibitors in cancer, Nyborg, Denmark, 14-18 June 1998. Biochim Biophys Acta. 1999 Jan 29;1423(1):R35–R44. doi: 10.1016/s0304-419x(98)00034-1. [DOI] [PubMed] [Google Scholar]
  6. Blumberg P. M., Robbins P. W. Effect of proteases on activation of resting chick embryo fibroblasts and on cell surface proteins. Cell. 1975 Oct;6(2):137–147. doi: 10.1016/0092-8674(75)90004-5. [DOI] [PubMed] [Google Scholar]
  7. Bohm S. K., Kong W., Bromme D., Smeekens S. P., Anderson D. C., Connolly A., Kahn M., Nelken N. A., Coughlin S. R., Payan D. G. Molecular cloning, expression and potential functions of the human proteinase-activated receptor-2. Biochem J. 1996 Mar 15;314(Pt 3):1009–1016. doi: 10.1042/bj3141009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bustos D., Tiscornia O., Caldarini M. I., Negri G., Pons S., Ogawa K., De Paula J. A. Colonic proteolysis following pancreatic duct ligation in the rat. Int J Pancreatol. 1994 Aug;16(1):45–49. doi: 10.1007/BF02925609. [DOI] [PubMed] [Google Scholar]
  9. Böhm S. K., Khitin L. M., Grady E. F., Aponte G., Payan D. G., Bunnett N. W. Mechanisms of desensitization and resensitization of proteinase-activated receptor-2. J Biol Chem. 1996 Sep 6;271(36):22003–22016. doi: 10.1074/jbc.271.36.22003. [DOI] [PubMed] [Google Scholar]
  10. Carney D. H., Cunningham D. D. Initiation of check cell division by trypsin action at the cell surface. Nature. 1977 Aug 18;268(5621):602–606. doi: 10.1038/268602a0. [DOI] [PubMed] [Google Scholar]
  11. Chirgwin J. M., Przybyla A. E., MacDonald R. J., Rutter W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 1979 Nov 27;18(24):5294–5299. doi: 10.1021/bi00591a005. [DOI] [PubMed] [Google Scholar]
  12. D'Andrea M. R., Derian C. K., Leturcq D., Baker S. M., Brunmark A., Ling P., Darrow A. L., Santulli R. J., Brass L. F., Andrade-Gordon P. Characterization of protease-activated receptor-2 immunoreactivity in normal human tissues. J Histochem Cytochem. 1998 Feb;46(2):157–164. doi: 10.1177/002215549804600204. [DOI] [PubMed] [Google Scholar]
  13. Darmoul D., Lacasa M., Baricault L., Marguet D., Sapin C., Trotot P., Barbat A., Trugnan G. Dipeptidyl peptidase IV (CD 26) gene expression in enterocyte-like colon cancer cell lines HT-29 and Caco-2. Cloning of the complete human coding sequence and changes of dipeptidyl peptidase IV mRNA levels during cell differentiation. J Biol Chem. 1992 Mar 5;267(7):4824–4833. [PubMed] [Google Scholar]
  14. DeFea K. A., Zalevsky J., Thoma M. S., Déry O., Mullins R. D., Bunnett N. W. beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2. J Cell Biol. 2000 Mar 20;148(6):1267–1281. doi: 10.1083/jcb.148.6.1267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Déry O., Corvera C. U., Steinhoff M., Bunnett N. W. Proteinase-activated receptors: novel mechanisms of signaling by serine proteases. Am J Physiol. 1998 Jun;274(6 Pt 1):C1429–C1452. doi: 10.1152/ajpcell.1998.274.6.C1429. [DOI] [PubMed] [Google Scholar]
  16. Green G. M., Nasset E. S. Importance of bile in regulation of intraluminal proteolytic enzyme activities in the rat. Gastroenterology. 1980 Oct;79(4):695–702. [PubMed] [Google Scholar]
  17. Hedström J., Haglund C., Haapiainen R., Stenman U. H. Serum trypsinogen-2 and trypsin-2-alpha(1)-antitrypsin complex in malignant and benign digestive-tract diseases. Preferential elevation in patients with cholangiocarcinomas. Int J Cancer. 1996 May 3;66(3):326–331. doi: 10.1002/(SICI)1097-0215(19960503)66:3<326::AID-IJC10>3.0.CO;2-9. [DOI] [PubMed] [Google Scholar]
  18. Hirahara F., Miyagi Y., Miyagi E., Yasumitsu H., Koshikawa N., Nagashima Y., Kitamura H., Minaguchi H., Umeda M., Miyazaki K. Trypsinogen expression in human ovarian carcinomas. Int J Cancer. 1995 Oct 9;63(2):176–181. doi: 10.1002/ijc.2910630205. [DOI] [PubMed] [Google Scholar]
  19. Hollenberg M. D. Protease-mediated signalling: new paradigms for cell regulation and drug development. Trends Pharmacol Sci. 1996 Jan;17(1):3–6. doi: 10.1016/0165-6147(96)81562-8. [DOI] [PubMed] [Google Scholar]
  20. Hollenberg M. D., Saifeddine M., al-Ani B., Kawabata A. Proteinase-activated receptors: structural requirements for activity, receptor cross-reactivity, and receptor selectivity of receptor-activating peptides. Can J Physiol Pharmacol. 1997 Jul;75(7):832–841. [PubMed] [Google Scholar]
  21. Ichikawa Y., Koshikawa N., Hasegawa S., Ishikawa T., Momiyama N., Kunizaki C., Takahashi M., Moriwaki Y., Akiyama H., Yamaoka H. Marked increase of trypsin(ogen) in serum of linitis plastica (gastric cancer, borrmann 4) patients. Clin Cancer Res. 2000 Apr;6(4):1385–1388. [PubMed] [Google Scholar]
  22. Ishihara H., Connolly A. J., Zeng D., Kahn M. L., Zheng Y. W., Timmons C., Tram T., Coughlin S. R. Protease-activated receptor 3 is a second thrombin receptor in humans. Nature. 1997 Apr 3;386(6624):502–506. doi: 10.1038/386502a0. [DOI] [PubMed] [Google Scholar]
  23. Kennedy A. R. Prevention of carcinogenesis by protease inhibitors. Cancer Res. 1994 Apr 1;54(7 Suppl):1999s–2005s. [PubMed] [Google Scholar]
  24. Kennedy A. R. The Bowman-Birk inhibitor from soybeans as an anticarcinogenic agent. Am J Clin Nutr. 1998 Dec;68(6 Suppl):1406S–1412S. doi: 10.1093/ajcn/68.6.1406S. [DOI] [PubMed] [Google Scholar]
  25. Kong W., McConalogue K., Khitin L. M., Hollenberg M. D., Payan D. G., Böhm S. K., Bunnett N. W. Luminal trypsin may regulate enterocytes through proteinase-activated receptor 2. Proc Natl Acad Sci U S A. 1997 Aug 5;94(16):8884–8889. doi: 10.1073/pnas.94.16.8884. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Koshikawa N., Hasegawa S., Nagashima Y., Mitsuhashi K., Tsubota Y., Miyata S., Miyagi Y., Yasumitsu H., Miyazaki K. Expression of trypsin by epithelial cells of various tissues, leukocytes, and neurons in human and mouse. Am J Pathol. 1998 Sep;153(3):937–944. doi: 10.1016/S0002-9440(10)65635-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Koshikawa N., Nagashima Y., Miyagi Y., Mizushima H., Yanoma S., Yasumitsu H., Miyazaki K. Expression of trypsin in vascular endothelial cells. FEBS Lett. 1997 Jun 16;409(3):442–448. doi: 10.1016/s0014-5793(97)00565-6. [DOI] [PubMed] [Google Scholar]
  28. Koshikawa N., Yasumitsu H., Umeda M., Miyazaki K. Multiple secretion of matrix serine proteinases by human gastric carcinoma cell lines. Cancer Res. 1992 Sep 15;52(18):5046–5053. [PubMed] [Google Scholar]
  29. Laburthe M., Rousset M., Rouyer-Fessard C., Couvineau A., Chantret I., Chevalier G., Zweibaum A. Development of vasoactive intestinal peptide-responsive adenylate cyclase during enterocytic differentiation of Caco-2 cells in culture. Evidence for an increased receptor level. J Biol Chem. 1987 Jul 25;262(21):10180–10184. [PubMed] [Google Scholar]
  30. Maoret J. J., Anini Y., Rouyer-Fessard C., Gully D., Laburthe M. Neurotensin and a non-peptide neurotensin receptor antagonist control human colon cancer cell growth in cell culture and in cells xenografted into nude mice. Int J Cancer. 1999 Jan 29;80(3):448–454. doi: 10.1002/(sici)1097-0215(19990129)80:3<448::aid-ijc19>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  31. Mazzieri R., Masiero L., Zanetta L., Monea S., Onisto M., Garbisa S., Mignatti P. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants. EMBO J. 1997 May 1;16(9):2319–2332. doi: 10.1093/emboj/16.9.2319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. McCawley L. J., Matrisian L. M. Matrix metalloproteinases: multifunctional contributors to tumor progression. Mol Med Today. 2000 Apr;6(4):149–156. doi: 10.1016/s1357-4310(00)01686-5. [DOI] [PubMed] [Google Scholar]
  33. Mignatti P., Rifkin D. B. Biology and biochemistry of proteinases in tumor invasion. Physiol Rev. 1993 Jan;73(1):161–195. doi: 10.1152/physrev.1993.73.1.161. [DOI] [PubMed] [Google Scholar]
  34. Mirza H., Schmidt V. A., Derian C. K., Jesty J., Bahou W. F. Mitogenic responses mediated through the proteinase-activated receptor-2 are induced by expressed forms of mast cell alpha- or beta-tryptases. Blood. 1997 Nov 15;90(10):3914–3922. [PubMed] [Google Scholar]
  35. Miyata S., Koshikawa N., Higashi S., Miyagi Y., Nagashima Y., Yanoma S., Kato Y., Yasumitsu H., Miyazaki K. Expression of trypsin in human cancer cell lines and cancer tissues and its tight binding to soluble form of Alzheimer amyloid precursor protein in culture. J Biochem. 1999 Jun;125(6):1067–1076. doi: 10.1093/oxfordjournals.jbchem.a022388. [DOI] [PubMed] [Google Scholar]
  36. Miyata S., Miyagi Y., Koshikawa N., Nagashima Y., Kato Y., Yasumitsu H., Hirahara F., Misugi K., Miyazaki K. Stimulation of cellular growth and adhesion to fibronectin and vitronectin in culture and tumorigenicity in nude mice by overexpression of trypsinogen in human gastric cancer cells. Clin Exp Metastasis. 1998 Oct;16(7):613–622. doi: 10.1023/a:1006576313979. [DOI] [PubMed] [Google Scholar]
  37. Molino M., Barnathan E. S., Numerof R., Clark J., Dreyer M., Cumashi A., Hoxie J. A., Schechter N., Woolkalis M., Brass L. F. Interactions of mast cell tryptase with thrombin receptors and PAR-2. J Biol Chem. 1997 Feb 14;272(7):4043–4049. doi: 10.1074/jbc.272.7.4043. [DOI] [PubMed] [Google Scholar]
  38. Molino M., Raghunath P. N., Kuo A., Ahuja M., Hoxie J. A., Brass L. F., Barnathan E. S. Differential expression of functional protease-activated receptor-2 (PAR-2) in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1998 May;18(5):825–832. doi: 10.1161/01.atv.18.5.825. [DOI] [PubMed] [Google Scholar]
  39. Molino M., Woolkalis M. J., Reavey-Cantwell J., Praticó D., Andrade-Gordon P., Barnathan E. S., Brass L. F. Endothelial cell thrombin receptors and PAR-2. Two protease-activated receptors located in a single cellular environment. J Biol Chem. 1997 Apr 25;272(17):11133–11141. doi: 10.1074/jbc.272.17.11133. [DOI] [PubMed] [Google Scholar]
  40. Nguyen T. D., Moody M. W., Steinhoff M., Okolo C., Koh D. S., Bunnett N. W. Trypsin activates pancreatic duct epithelial cell ion channels through proteinase-activated receptor-2. J Clin Invest. 1999 Jan;103(2):261–269. doi: 10.1172/JCI2539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Normanno N., De Luca A., Salomon D. S., Ciardiello F. Epidermal growth factor-related peptides as targets for experimental therapy of human colon carcinoma. Cancer Detect Prev. 1998;22(1):62–67. [PubMed] [Google Scholar]
  42. Nystedt S., Emilsson K., Larsson A. K., Strömbeck B., Sundelin J. Molecular cloning and functional expression of the gene encoding the human proteinase-activated receptor 2. Eur J Biochem. 1995 Aug 15;232(1):84–89. doi: 10.1111/j.1432-1033.1995.tb20784.x. [DOI] [PubMed] [Google Scholar]
  43. Nystedt S., Emilsson K., Wahlestedt C., Sundelin J. Molecular cloning of a potential proteinase activated receptor. Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9208–9212. doi: 10.1073/pnas.91.20.9208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. O'Brien P. J., Molino M., Kahn M., Brass L. F. Protease activated receptors: theme and variations. Oncogene. 2001 Mar 26;20(13):1570–1581. doi: 10.1038/sj.onc.1204194. [DOI] [PubMed] [Google Scholar]
  45. Ramos-DeSimone N., Hahn-Dantona E., Sipley J., Nagase H., French D. L., Quigley J. P. Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion. J Biol Chem. 1999 May 7;274(19):13066–13076. doi: 10.1074/jbc.274.19.13066. [DOI] [PubMed] [Google Scholar]
  46. Saifeddine M., al-Ani B., Cheng C. H., Wang L., Hollenberg M. D. Rat proteinase-activated receptor-2 (PAR-2): cDNA sequence and activity of receptor-derived peptides in gastric and vascular tissue. Br J Pharmacol. 1996 Jun;118(3):521–530. doi: 10.1111/j.1476-5381.1996.tb15433.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Singh P., Rubin N. Insulinlike growth factors and binding proteins in colon cancer. Gastroenterology. 1993 Oct;105(4):1218–1237. doi: 10.1016/0016-5085(93)90971-e. [DOI] [PubMed] [Google Scholar]
  48. Singh P., Velasco M., Given R., Wargovich M., Varro A., Wang T. C. Mice overexpressing progastrin are predisposed for developing aberrant colonic crypt foci in response to AOM. Am J Physiol Gastrointest Liver Physiol. 2000 Mar;278(3):G390–G399. doi: 10.1152/ajpgi.2000.278.3.G390. [DOI] [PubMed] [Google Scholar]
  49. Smith R., Jenkins A., Lourbakos A., Thompson P., Ramakrishnan V., Tomlinson J., Deshpande U., Johnson D. A., Jones R., Mackie E. J. Evidence for the activation of PAR-2 by the sperm protease, acrosin: expression of the receptor on oocytes. FEBS Lett. 2000 Nov 10;484(3):285–290. doi: 10.1016/s0014-5793(00)02146-3. [DOI] [PubMed] [Google Scholar]
  50. Sorsa T., Salo T., Koivunen E., Tyynelä J., Konttinen Y. T., Bergmann U., Tuuttila A., Niemi E., Teronen O., Heikkilä P. Activation of type IV procollagenases by human tumor-associated trypsin-2. J Biol Chem. 1997 Aug 22;272(34):21067–21074. doi: 10.1074/jbc.272.34.21067. [DOI] [PubMed] [Google Scholar]
  51. Vergnolle N., Macnaughton W. K., Al-Ani B., Saifeddine M., Wallace J. L., Hollenberg M. D. Proteinase-activated receptor 2 (PAR2)-activating peptides: identification of a receptor distinct from PAR2 that regulates intestinal transport. Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7766–7771. doi: 10.1073/pnas.95.13.7766. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Vergnolle N. Review article: proteinase-activated receptors - novel signals for gastrointestinal pathophysiology. Aliment Pharmacol Ther. 2000 Mar;14(3):257–266. doi: 10.1046/j.1365-2036.2000.00690.x. [DOI] [PubMed] [Google Scholar]
  53. Vu T. K., Hung D. T., Wheaton V. I., Coughlin S. R. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell. 1991 Mar 22;64(6):1057–1068. doi: 10.1016/0092-8674(91)90261-v. [DOI] [PubMed] [Google Scholar]
  54. Xu W. F., Andersen H., Whitmore T. E., Presnell S. R., Yee D. P., Ching A., Gilbert T., Davie E. W., Foster D. C. Cloning and characterization of human protease-activated receptor 4. Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):6642–6646. doi: 10.1073/pnas.95.12.6642. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Yu Z., Ahmad S., Schwartz J. L., Banville D., Shen S. H. Protein-tyrosine phosphatase SHP2 is positively linked to proteinase-activated receptor 2-mediated mitogenic pathway. J Biol Chem. 1997 Mar 14;272(11):7519–7524. doi: 10.1074/jbc.272.11.7519. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES